GO:0016101 diterpenoid metabolic process: Biosynthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016101 diterpenoid metabolic process describes the chemical reactions and pathways involving diterpenoid compounds, which are terpenoids built from four isoprene units.
• Diterpenoids are a structurally diverse class of natural products with more than 100 distinct carbon skeletons, including ent-atisane, ingenane, and neo-clerodane frameworks [2,3,5].
• The pathway is initiated by diterpenoid synthases (diTPS) that convert geranylgeranyl diphosphate (GGPP) into labdane-related diterpene scaffolds, which are then decorated by cytochrome P450 monooxygenases and glycosyltransferases [2,6].
• Diterpenoid metabolic process is directly linked to human disease: andrographolide and berbamine synergistically affect glioblastoma proteomic and metabolomic pathways, while brunodelphinine A alleviates non-alcoholic fatty liver disease via the NOX4/SIRT1/PPARs axis.
• Alterbrassicene A nanoparticles inhibit aortic valve calcification by suppressing P65 NF-kB phosphorylation, demonstrating the therapeutic potential of diterpenoid-based nanomedicine.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for dissecting the causal roles of diterpenoid biosynthetic genes in disease and metabolism [1,4,7].
Description
Diterpenoid metabolic process (GO:0016101) is a biological process defined as the chemical reactions and pathways involving diterpenoid compounds, which are terpenoids with four isoprene units. Diterpenoids constitute one of the largest and most structurally diverse families of natural products, with over 100 distinct carbon skeletons reported from terrestrial organisms [2,6]. These compounds serve essential physiological roles in plants, fungi, and marine organisms, and many possess potent pharmacological activities relevant to human health [2,5]. The pathway encompasses the biosynthesis, modification, and interconversion of diterpenoid molecules, beginning with the cyclization of geranylgeranyl diphosphate (GGPP) by diterpenoid synthases and followed by oxidative tailoring by cytochrome P450 enzymes and other modifying enzymes [2,6]. Understanding diterpenoid metabolic process is critical for researchers in natural product chemistry, pharmacology, and metabolic engineering. Recent studies have demonstrated that diterpenoids such as andrographolide and berbamine exhibit synergistic anti-glioblastoma effects through proteomic and metabolomic pathway remodeling. Similarly, brunodelphinine A alleviates non-alcoholic fatty liver disease by inhibiting oxidative stress and regulating lipid metabolism via the NOX4/SIRT1/PPARs axis. These findings underscore the therapeutic relevance of diterpenoid metabolism and the need for precise genetic tools to study the enzymes and regulatory networks involved [1,4]. The structural complexity of diterpenoids, including ent-atisane, ingenane, and neo-clerodane frameworks, presents both opportunities and challenges for drug discovery and metabolic engineering [3,5,8]. CRISPR-based gene editing has emerged as a powerful approach to dissect the genetic basis of diterpenoid biosynthesis and to engineer cell factories for production of high-value diterpenoid compounds [2,6].
diterpenoid metabolic process At A Glance
| GO ID | GO:0016101 |
|---|---|
| GO term | diterpenoid metabolic process |
| Ontology | biological_process |
| Synonym | diterpene metabolic process; diterpene metabolism; diterpenoid metabolism |
| Definition | The chemical reactions and pathways involving diterpenoid compounds, terpenoids with four isoprene units. |
| Major function | Biosynthesis, modification, and interconversion of C20 terpenoid natural products |
| Key precursor | Geranylgeranyl diphosphate (GGPP) |
| Representative enzymes | Diterpenoid synthases (diTPS), cytochrome P450 monooxygenases, glycosyltransferases |
| Representative compounds | Andrographolide, berbamine, brunodelphinine A, alterbrassicene A, ent-atisane diterpenoids |
What Is GO:0016101?
GO:0016101 diterpenoid metabolic process refers to the chemical reactions and pathways involving diterpenoid compounds, which are terpenoids composed of four isoprene units (C20). This process includes the biosynthesis of diterpenoid scaffolds from geranylgeranyl diphosphate (GGPP), the enzymatic modification of these scaffolds by cytochrome P450 monooxygenases, glycosyltransferases, and other tailoring enzymes, as well as the catabolism and interconversion of diterpenoid molecules [2,6]. The term is synonymous with diterpene metabolic process, diterpene metabolism, and diterpenoid metabolism.
Why Is diterpenoid metabolic process Important in Cell Biology?
Diterpenoid metabolic process is fundamentally important because it governs the production of thousands of bioactive natural products that serve as drugs, agrochemicals, and industrial compounds [2,6]. Many diterpenoids exhibit anti-inflammatory, anticancer, antiviral, and cardioprotective activities, making the pathway a rich source of therapeutic leads [1,4,7,8]. Understanding the enzymes and regulatory mechanisms of diterpenoid metabolism enables rational metabolic engineering and synthetic biology approaches to produce high-value diterpenoids sustainably [2,5].
• Diterpenoids represent one of the largest classes of plant natural products with diverse pharmacological activities.
• The pathway produces clinically relevant compounds such as andrographolide, which shows synergistic anti-glioblastoma effects.
• Brunodelphinine A from diterpenoid metabolism alleviates non-alcoholic fatty liver disease via NOX4/SIRT1/PPARs signaling.
• Alterbrassicene A nanoparticles inhibit aortic valve calcification by suppressing NF-kB phosphorylation.
• Neo-clerodane diterpenoids from Ajuga pantantha exhibit anti-inflammatory activity.
• Ent-atisane diterpenoids display diverse bioactivities including antimicrobial and cytotoxic effects.
• Ingenane diterpenoids are important leads for anticancer drug development.
• The pathway is a target for metabolic engineering to produce high-value diterpenoid pharmaceuticals [2,6].
• Diterpenoid biosynthetic genes are potential targets for crop improvement and plant defense enhancement.
• CRISPR-based editing of diterpenoid pathway genes enables functional genomics and strain improvement [1,4].
What Happens During diterpenoid metabolic process?
Initiation: GGPP biosynthesis and cyclization
In simple terms: The pathway starts when a 20-carbon building block called GGPP is folded into a ring structure by specialized enzymes.
Diterpenoid metabolism begins with the synthesis of geranylgeranyl diphosphate (GGPP), a C20 isoprenoid precursor formed by the sequential addition of isopentenyl diphosphate units to farnesyl diphosphate [2,6]. Diterpenoid synthases (diTPS), also known as diterpene cyclases, then catalyze the ionization and cyclization of GGPP to form labdane-related diterpene scaffolds. These enzymes are responsible for generating the remarkable structural diversity of diterpenoid carbon skeletons, including ent-atisane, ingenane, and neo-clerodane frameworks [2,3,5]. The cyclization reaction typically involves carbocation intermediates that are quenched by deprotonation or water capture, yielding a wide array of bicyclic, tricyclic, and tetracyclic products [2,6].
Oxidative tailoring by cytochrome P450 enzymes
In simple terms: After the core ring structure is made, a family of enzymes called P450s adds oxygen atoms to create functional groups.
Following cyclization, diterpene scaffolds undergo oxidative modifications catalyzed primarily by cytochrome P450 monooxygenases (CYP450s). These enzymes introduce hydroxyl, carboxyl, and epoxide groups at specific positions on the diterpenoid skeleton, dramatically increasing chemical diversity and biological activity [2,6]. For example, the biosynthesis of andrographolide involves multiple P450-mediated oxidation steps that convert the initial labdane scaffold into the bioactive labdane diterpenoid lactone. Similarly, the production of neo-clerodane diterpenoids in Ajuga pantantha requires P450 enzymes for oxidative tailoring. These modifications are essential for the pharmacological properties of diterpenoids, including their anti-inflammatory and anticancer activities [1,4,8].
Glycosylation and further decoration
In simple terms: Sugar molecules are attached to diterpenoids to make them more stable and water-soluble.
Glycosyltransferases (GTs) catalyze the transfer of sugar moieties from UDP-sugars to diterpenoid aglycones, producing diterpenoid glycosides. This glycosylation step enhances the solubility, stability, and bioactivity of diterpenoids [2,6]. In some plants, additional modifications such as methylation, acylation, and prenylation further diversify the diterpenoid repertoire. These tailoring reactions are often species-specific and contribute to the enormous chemical diversity observed in diterpenoid natural products [5,6].
Catabolism and interconversion
In simple terms: Diterpenoids can be broken down or converted into other related compounds.
Diterpenoid metabolic process also includes catabolic reactions that degrade diterpenoids into simpler metabolites, as well as interconversion reactions that transform one diterpenoid into another. These reactions are important for maintaining metabolic homeostasis and for the turnover of bioactive diterpenoids in planta. In some cases, catabolic enzymes such as glycosidases and esterases remove sugar or ester groups to regenerate bioactive aglycones. The balance between biosynthesis and catabolism determines the steady-state levels of specific diterpenoids in plant tissues.
Transport and subcellular compartmentalization
In simple terms: Different steps of the pathway happen in different parts of the cell.
Diterpenoid biosynthesis is compartmentalized within plant cells. GGPP synthesis occurs in the plastid, while diterpenoid synthases are localized to plastids or the endoplasmic reticulum [2,6]. Cytochrome P450 enzymes are anchored in the endoplasmic reticulum membrane, where they catalyze oxidative modifications. Glycosyltransferases are typically cytosolic or membrane-associated. This spatial organization ensures efficient substrate channeling and prevents toxic intermediates from accumulating. Understanding the subcellular localization of diterpenoid biosynthetic enzymes is essential for metabolic engineering strategies.
Key Genes Involved in GO:0016101 diterpenoid metabolic process
The following genes and enzymes are central to diterpenoid metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| diTPS | Diterpenoid synthase catalyzing GGPP cyclization | Generates diterpenoid scaffolds; target for metabolic engineering [2,6] |
| CYP450 | Cytochrome P450 monooxygenase for oxidative tailoring | Introduces functional groups; determines bioactivity [2,6] |
| GT | Glycosyltransferase for sugar attachment | Enhances solubility and stability of diterpenoids [2,6] |
| GGPPS | Geranylgeranyl diphosphate synthase | Provides C20 precursor for diterpenoid biosynthesis |
| NOX4 | NADPH oxidase 4 | Mediates oxidative stress in NAFLD; target of brunodelphinine A |
| SIRT1 | Sirtuin 1 deacetylase | Regulates lipid metabolism and oxidative stress |
| PPARs | Peroxisome proliferator-activated receptors | Regulate lipid metabolism; modulated by diterpenoids |
| NF-kB | Nuclear factor kappa-B | Inflammatory signaling; suppressed by alterbrassicene A |
| P65 | NF-kB subunit p65/RelA | Phosphorylation target in aortic valve calcification |
| Bcl-2 | Apoptosis regulator | Modulated by andrographolide in glioblastoma |
| Bax | Pro-apoptotic protein | Affected by andrographolide/berbamine combination |
| Caspase-3 | Executioner caspase | Activated in diterpenoid-induced apoptosis |
| COX-2 | Cyclooxygenase-2 | Inflammatory enzyme inhibited by neo-clerodane diterpenoids |
| iNOS | Inducible nitric oxide synthase | Anti-inflammatory target of diterpenoids |
| TNF-alpha | Tumor necrosis factor alpha | Pro-inflammatory cytokine modulated by diterpenoids |
| IL-6 | Interleukin-6 | Inflammatory cytokine affected by diterpenoid treatment |
| MMP-9 | Matrix metalloproteinase-9 | Involved in tissue remodeling; regulated by diterpenoids |
How Is diterpenoid metabolic process Regulated?
Diterpenoid metabolic process is regulated at multiple levels, including transcriptional control of biosynthetic genes, post-translational modification of enzymes, and feedback inhibition by pathway intermediates [2,6]. In plants, jasmonate signaling is a major regulator of diterpenoid biosynthesis, inducing the expression of diTPS and CYP450 genes in response to herbivory or wounding. In mammals, diterpenoid compounds such as brunodelphinine A modulate signaling pathways including NOX4/SIRT1/PPARs, which in turn regulate oxidative stress and lipid metabolism. Additionally, NF-kB signaling is a key regulatory node affected by diterpenoids such as alterbrassicene A, which suppresses P65 phosphorylation. These regulatory mechanisms provide multiple entry points for pharmacological intervention and metabolic engineering [2,4,7].
diterpenoid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOX4 | Non-alcoholic fatty liver disease | NOX4 knockout hepatocytes treated with brunodelphinine A |
| SIRT1 | NAFLD / lipid metabolism | SIRT1 overexpression or knockout in liver cells |
| PPARs | NAFLD / metabolic syndrome | PPAR knockout or knock-in models |
| NF-kB (P65) | Aortic valve calcification | P65 point-mutation knock-in in valve interstitial cells |
| COX-2 | Inflammation | COX-2 knockout macrophages treated with neo-clerodane diterpenoids |
Diterpenoids in cancer: glioblastoma and beyond
Andrographolide, a labdane diterpenoid, exhibits synergistic anti-glioblastoma effects when combined with berbamine, as revealed by proteomic and metabolomic pathway analysis. The combination modulates multiple metabolic and signaling pathways, including apoptosis regulators such as Bcl-2, Bax, and caspase-3. These findings suggest that diterpenoid metabolic process is directly relevant to cancer therapy, and that targeting diterpenoid biosynthetic enzymes could enhance chemosensitivity.
Diterpenoids in metabolic liver disease
Brunodelphinine A, a diterpenoid compound, alleviates non-alcoholic fatty liver disease (NAFLD) by inhibiting oxidative stress and regulating lipid metabolism via the NOX4/SIRT1/PPARs axis. This study demonstrates that diterpenoids can modulate key metabolic regulators, including sirtuins and PPARs, which are central to hepatic lipid homeostasis. The findings support the potential of diterpenoid-based therapeutics for metabolic disorders.
Diterpenoids in cardiovascular calcification
Alterbrassicene A, a diterpenoid natural product, when formulated as platelet membrane-coated nanoparticles, inhibits calcification of the aortic valve by suppressing phosphorylation of P65 NF-kB. This highlights the anti-inflammatory and anti-calcific properties of diterpenoids and their potential in cardiovascular disease. The study also illustrates how nanomedicine can enhance the delivery and efficacy of diterpenoid compounds.
Diterpenoids in inflammation
Neo-clerodane diterpenoids isolated from Ajuga pantantha exhibit anti-inflammatory activity by inhibiting pro-inflammatory mediators such as COX-2, iNOS, TNF-alpha, and IL-6. These findings underscore the therapeutic potential of diterpenoids in inflammatory diseases and provide a rationale for investigating their biosynthetic pathways.
From diterpenoid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does diTPS gene X control diterpenoid scaffold diversity? | CRISPR knockout of diTPS in plant or yeast cells [2,6] |
| Does a point mutation in CYP450 alter diterpenoid bioactivity? | CRISPR point-mutation knock-in in CYP450 locus [2,6] |
| Can overexpression of GGPPS increase diterpenoid yield? | CRISPR-mediated overexpression of GGPPS in metabolic engineering host |
| Does NOX4 mediate brunodelphinine A effects in NAFLD? | NOX4 knockout or knock-in hepatocyte models |
| Does P65 phosphorylation drive aortic valve calcification? | P65 phospho-mutant knock-in in valve interstitial cells |
| Does SIRT1 regulate PPARs in diterpenoid-treated cells? | SIRT1 knockout and overexpression models |
How to Study the diterpenoid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Identify diterpenoid biosynthetic genes [2,6] |
| LC-MS | Diterpenoid metabolite profiles | Quantify pathway intermediates and end products [2,6] |
| GC-MS | Volatile diterpenoid compounds | Analyze diterpene hydrocarbons |
| Proteomics | Protein expression and modifications | Dissect diterpenoid effects on signaling pathways |
| Metabolomics | Global metabolite changes | Pathway analysis in disease models |
| Enzyme assays | Catalytic activity and kinetics | Functional characterization of diTPS and CYP450 [2,6] |
| CRISPR screening | Gene function at scale | Identify regulators of diterpenoid metabolism [2,6] |
| Immunoblotting | Protein phosphorylation and expression | Validate NF-kB, SIRT1, PPARs signaling [4,7] |
Genomic and transcriptomic profiling
RNA-seq and whole-genome sequencing are used to identify diterpenoid biosynthetic gene clusters and to quantify expression of diTPS, CYP450, and GT genes under different conditions [2,6]. Comparative transcriptomics between high- and low-diterpenoid-producing plant varieties can reveal candidate genes for metabolic engineering.
Proteomic and metabolomic analysis
Proteomic and metabolomic pathway analysis has been used to dissect the synergistic effects of andrographolide and berbamine in glioblastoma, revealing changes in apoptosis and metabolic pathways. LC-MS and GC-MS are standard methods for profiling diterpenoid metabolites and their intermediates [2,6].
Enzyme activity assays
In vitro enzyme assays using recombinant diTPS and CYP450 proteins are used to characterize substrate specificity, kinetic parameters, and product profiles [2,6]. These assays are essential for functional annotation of diterpenoid biosynthetic genes.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of diterpenoid pathway genes in disease and metabolic contexts [1,4,7]. For example, NOX4 knockout and SIRT1 overexpression models have been used to validate the mechanism of brunodelphinine A in NAFLD.
How CRISPR Can Be Used to Study GO:0016101 diterpenoid metabolic process
Knockout
CRISPR knockout of diterpenoid biosynthetic genes such as diTPS, CYP450, and GT enables loss-of-function studies to determine their essentiality in diterpenoid production and disease models [2,6]. For example, NOX4 knockout hepatocytes have been used to validate the mechanism of brunodelphinine A in NAFLD.
Point Mutation
CRISPR point-mutation knock-in allows precise modification of catalytic residues or regulatory phosphorylation sites in diterpenoid enzymes and signaling proteins. For instance, P65 phospho-mutant knock-in can test the role of NF-kB phosphorylation in aortic valve calcification.
Knock-in
CRISPR knock-in of reporter tags or epitope tags into diterpenoid biosynthetic genes enables real-time monitoring of enzyme localization and expression [2,6]. Knock-in of disease-associated mutations can model human disorders linked to diterpenoid metabolism [4,7].
Overexpression
CRISPR-mediated overexpression of rate-limiting enzymes such as GGPPS or diTPS can boost diterpenoid production in engineered hosts [2,6]. Overexpression of SIRT1 or PPARs can test their protective roles in metabolic disease models.
How EDITGENE Supports diterpenoid metabolic process Research
Researchers studying diterpenoid metabolic process-related genes often need to determine whether a candidate gene is causally involved in diterpenoid biosynthesis, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR gene editing services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for diterpenoid metabolic process research.
Frequently Asked Questions About diterpenoid metabolic process
What is GO:0016101 diterpenoid metabolic process?
GO:0016101 diterpenoid metabolic process is a biological process defined as the chemical reactions and pathways involving diterpenoid compounds, which are terpenoids with four isoprene units.
What genes are involved in diterpenoid metabolic process?
Key genes include diterpenoid synthases (diTPS), cytochrome P450 monooxygenases (CYP450), glycosyltransferases (GT), and GGPPS, as well as disease-related genes such as NOX4, SIRT1, PPARs, and NF-kB [2,4,6,7].
What are diterpenoids?
Diterpenoids are terpenoid compounds composed of four isoprene units (C20), with over 100 distinct carbon skeletons including ent-atisane, ingenane, and neo-clerodane frameworks [2,3,5].
How are diterpenoids synthesized?
Diterpenoids are synthesized from geranylgeranyl diphosphate (GGPP) by diterpenoid synthases, followed by oxidative tailoring by cytochrome P450 enzymes and glycosylation by glycosyltransferases [2,6].
What diseases are linked to diterpenoid metabolic process?
Diterpenoids are linked to glioblastoma, non-alcoholic fatty liver disease, aortic valve calcification, and inflammation.
How can CRISPR be used to study diterpenoid metabolic process?
CRISPR knockout, point-mutation, knock-in, and overexpression models enable functional dissection of diterpenoid biosynthetic genes and their roles in disease [1,4,7].
What is the role of andrographolide in cancer?
Andrographolide, a diterpenoid, shows synergistic anti-glioblastoma effects with berbamine by modulating proteomic and metabolomic pathways.
How does brunodelphinine A treat NAFLD?
Brunodelphinine A alleviates NAFLD by inhibiting oxidative stress and regulating lipid metabolism via the NOX4/SIRT1/PPARs axis.
What are ent-atisane diterpenoids?
Ent-atisane diterpenoids are a class of diterpenoids with diverse bioactivities, including antimicrobial and cytotoxic effects.
What research methods are used to study diterpenoid metabolism?
Common methods include RNA-seq, LC-MS, GC-MS, proteomics, metabolomics, enzyme assays, and CRISPR screening [1,2,6].
Conclusion
Diterpenoid metabolic process (GO:0016101) is a central biological pathway responsible for the biosynthesis and modification of a vast array of bioactive natural products. From anticancer and anti-inflammatory activities to metabolic and cardiovascular protection, diterpenoids offer immense therapeutic potential [1,4,7,8]. Understanding the genes, enzymes, and regulatory mechanisms of this pathway is essential for drug discovery and metabolic engineering [2,6]. CRISPR-based gene editing provides unprecedented opportunities to dissect diterpenoid metabolism and to develop novel therapeutics. EDITGENE offers comprehensive CRISPR services, including knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics, to support researchers in advancing diterpenoid science [1,2,4,6,7].
References
- 1. Prakash V et al.. 2026. Synergistic effects of andrographolide and berbamine in glioblastoma: insights from proteomic and metabolomic pathway analysis.. Bioorg Chem 179:110006 PMID: 42172796
- 2. Hanson JR et al.. 2019. Diterpenoids of terrestrial origin.. Nat Prod Rep 36(11):1499-1512 PMID: 31417997
- 3. Appendino G. 2016. Ingenane Diterpenoids.. Prog Chem Org Nat Prod 102:1-90 PMID: 27380406
- 4. Wang M et al.. 2025. Brunodelphinine A alleviates non-alcoholic fatty liver disease by inhibiting oxidative stress and regulating lipid metabolism via NOX4/SIRT1/PPARs axis.. Phytomedicine 147:157202 PMID: 40907406
- 5. Drummond GJ et al.. 2021. ent-Atisane diterpenoids: isolation, structure and bioactivity.. Nat Prod Rep 38(2):330-345 PMID: 32716458
- 6. Hanson JR. 2017. Diterpenoids of terrestrial origin.. Nat Prod Rep 34(10):1233-1243 PMID: 28875214
- 7. Geng B et al.. 2023. Platelet membrane-coated alterbrassicene A nanoparticle inhibits calcification of the aortic valve by suppressing phosphorylation P65 NF-κB.. Theranostics 13(11):3781-3793 PMID: 37441596
- 8. Dong B et al.. 2020. Anti-inflammatory neo-Clerodane Diterpenoids from Ajuga pantantha.. J Nat Prod 83(4):894-904 PMID: 32216313
